New cholesterol-lowering drug could help patients unable to take statins
A new class of oral cholesterol-lowering drug could help patients unable to take statins due to side effects.
Mar 13, 2019
0
367
A new class of oral cholesterol-lowering drug could help patients unable to take statins due to side effects.
Mar 13, 2019
0
367
Individuals who take cholesterol-lowering statins may be at higher risk for developing high blood sugar levels, insulin resistance, and eventually type 2 diabetes, according to an analysis published in the British Journal ...
Mar 6, 2019
0
3
Patients who took statins less than 70 percent of the time had a 20 percent increase in mortality compared with those taking them at least 90 percent of the time, a Stanford study found.
Feb 22, 2019
1
130
Clinical trials have shown that cholesterol-lowering statin drugs can significantly reduce the risk of cardiovascular disease in kidney disease patients who are not on dialysis.
Feb 19, 2019
0
17
Clinicians should consider using PCSK9 inhibitors to lower cholesterol in patients with statin-associated autoimmune myopathy. Findings from a case report are published in the Annals of Internal Medicine.
Feb 19, 2019
0
5
The study assessed the effects of statins in nearly 187,000 people who had taken part in 28 large clinical trials. Participants were divided into six age groups (under 55 years, 55-60, 60-65, 65-70, 70-75, and over 75 years) ...
Jan 31, 2019
0
70
(HealthDay)—Would you stop taking a medication if you heard a negative news story about it?
Jan 17, 2019
0
0
(HealthDay)—For Taiwanese patients with type 2 diabetes and dyslipidemia, statin therapy is associated with a reduced risk for diabetic retinopathy, according to a study published online Jan. 10 in JAMA Ophthalmology.
Jan 11, 2019
0
3
(HealthDay)—For patients with a recent acute coronary syndrome receiving a statin, the price of alirocumab would have to be reduced to be cost-effective, according to a study published online Jan. 1 in the Annals of Internal ...
Jan 2, 2019
0
1
Statin treatment exhibits a beneficial effect in patients of cardiovascular diseases (CVD) and non-alcoholic fatty liver disease (NAFLD). Statins are common treatments for such conditions.
Jan 2, 2019
0
0